Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

N-Methyl-D-aspartate (NMDA) and cannabinoid CB receptors form functional complexes in cells of the central nervous system, insights into the therapeutic potential of neuronal and microglial NMDA receptors

  • Rivas Santisteban, Rafael|||0000-0002-2078-6819
  • Lillo, Alejandro
  • Lillo Jové, Jaume|||0000-0001-7712-0850
  • Rebassa, Joan Biel
  • Contestí, Joan S.
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Franco, Rafael|||0000-0003-2549-4919
  • Navarro Brugal, Gemma|||0000-0003-4654-0873
The cannabinoid CB receptor (CBR), which is a target to afford neuroprotection, and N-methyl-D-aspartate (NMDA) ionotropic glutamate receptors, which are key in mediating excitatory neurotransmission, are expressed in both neurons and glia. As NMDA receptors are the target of current medication in Alzheimer's disease patients and with the aim of finding neuromodulators of their actions that could provide benefits in dementia, we hypothesized that cannabinoids could modulate NMDA function. Immunocytochemistry was used to analyze the colocalization between CB and NMDA receptors; bioluminescence resonance energy transfer was used to detect CB-NMDA receptor complexes. Calcium and cAMP determination, mitogen-activated protein kinase (MAPK) pathway activation, and label-free assays were performed to characterize signaling in homologous and heterologous systems. Proximity ligation assays were used to quantify CB-NMDA heteromer expression in mouse primary cultures and in the brain of APP transgenic mice, an Alzheimer's disease model expressing the Indiana and Swedish mutated version of the human amyloid precursor protein (APP). In a heterologous system, we identified CB-NMDA complexes with a particular heteromer print consisting of impairment by cannabinoids of NMDA receptor function. The print was detected in activated primary microglia treated with lipopolysaccharide and interferon-γ. CBR activation blunted NMDA receptor-mediated signaling in primary hippocampal neurons from APP mice. Furthermore, imaging studies showed that in brain slices and in primary cells (microglia or neurons) from APP mice, there was a marked overexpression of macromolecular CB-NMDA receptor complexes thus becoming a tool to modulate excessive glutamate input by cannabinoids. The results indicate a negative cross-talk in CB-NMDA complexes signaling. The expression of the CB-NMDA receptor heteromers increases in both microglia and neurons from the APP transgenic mice, compared with levels in samples from age-matched control mice. The online version contains supplementary material available at 10.1186/s13195-021-00920-6.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Tissue Clearing and Expansion Methods for Imaging Brain Pathology in Neurodegeneration, From Circuits to Synapses and Beyond

  • Parra-Damas, Arnaldo|||0000-0001-5683-060X
  • Saura Antolín, Carlos|||0000-0003-3692-5657
Studying the structural alterations occurring during diseases of the nervous system requires imaging heterogeneous cell populations at the circuit, cellular and subcellular levels. Recent advancements in brain tissue clearing and expansion methods allow unprecedented detailed imaging of the nervous system through its entire scale, from circuits to synapses, including neurovascular and brain lymphatics elements. Here, we review the state-of-the-art of brain tissue clearing and expansion methods, mentioning their main advantages and limitations, and suggest their parallel implementation for circuits-to-synapses brain imaging using conventional (diffraction-limited) light microscopy -such as confocal, two-photon and light-sheet microscopy- to interrogate the cellular and molecular basis of neurodegenerative diseases. We discuss recent studies in which clearing and expansion methods have been successfully applied to study neuropathological processes in mouse models and postmortem human brain tissue. Volumetric imaging of cleared intact mouse brains and large human brain samples has allowed unbiased assessment of neuropathological hallmarks. In contrast, nanoscale imaging of expanded cells and brain tissue has been used to study the effect of protein aggregates on specific subcellular structures. Therefore, these approaches can be readily applied to study a wide range of brain processes and pathological mechanisms with cellular and subcellular resolution in a time- and cost-efficient manner. We consider that a broader implementation of these technologies is necessary to reveal the full landscape of cellular and molecular mechanisms underlying neurodegenerative diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex differences in fear memory consolidation via Tac2 signaling in mice

  • Florido Torres, Antonio Luis|||0000-0001-6184-0706
  • Velasco García, Eric Raúl|||0000-0002-8778-5618
  • Soto Faguas, Carlos Manuel|||0000-0003-2954-4987
  • Gomez-Gomez, A.|||0000-0001-8172-1827
  • Perez-Caballero, Laura|||0000-0002-2315-2213
  • Molina Molina, Patricia|||0000-0002-4118-4702
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
  • Pozo, Oscar J.|||0000-0002-1735-9728
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Andero Galí, Raül|||0000-0003-3641-8903
Memory formation is key for brain functioning. Uncovering the memory mechanisms is helping us to better understand neural processes in health and disease. Moreover, more specific treatments for fear-related disorders such as posttraumatic stress disorder and phobias may help to decrease their negative impact on mental health. In this line, the Tachykinin 2 (Tac2) pathway in the central amygdala (CeA) has been shown to be sufficient and necessary for the modulation of fear memory consolidation. CeA-Tac2 antagonism and its pharmacogenetic temporal inhibition impair fear memory in male mice. Surprisingly, we demonstrate here the opposite effect of Tac2 blockade on enhancing fear memory consolidation in females. Furthermore, we show that CeA-testosterone in males, CeA-estradiol in females and Akt/GSK3β/β-Catenin signaling both mediate the opposite-sex differential Tac2 pathway regulation of fear memory. The Tachykinin 2 (Tac2) pathway in the central amygdala is sufficient and necessary for modulating fear memory consolidation. The authors show that silencing Tac2 neurons in the amygdala of male mice reduces fear expression, while fear expression in female mice is increased when manipulations are made during proestrus.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Expression of Cellular Prion Protein, PrPC, Favors pTau Propagation and Blocks NMDAR Signaling in Primary Cortical Neurons

  • Rivas Santisteban, Rafael|||0000-0002-2078-6819
  • Raïch, Iu|||0000-0001-6271-0495
  • Aguinaga Andrés, David|||0000-0003-2506-7204
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Franco, Rafael|||0000-0003-2549-4919
  • Navarro Brugal, Gemma|||0000-0003-4654-0873
Background: The N-methyl-D-aspartate receptor (NMDAR) is a target in current treatments for Alzheimer's disease (AD). The human prion protein (PrPC) has an important role in the pathophysiology of AD. We hypothesized that PrPC modulates NMDA signaling, thus being a process associated with Alzheimer's disease. Methods: NMDAR signaling was characterized in the absence or presence of PrPC in cAMP level determination, mitogen-activated protein kinase (MAPK) pathway and label-free assays in homologous and heterologous systems. Bioluminescence resonance energy transfer was used to detect the formation of NMDAR-PrPC complexes. AXIS™ Axon Isolation Devices were used to determine axonal transport of Tau and pTau proteins in cortical primary neurons in the absence or presence of PrPC. Finally, proximity ligation assays were used to quantify NMDA-PrPC complex formation in neuronal primary cultures isolated from APP transgenic mice, an Alzheimer's disease model expressing the Indiana and Swedish mutated version of the human amyloid precursor protein (APP). Results: We discovered a direct interaction between the PrPC and the NMDAR and we found a negative modulation of NMDAR-mediated signaling due to the NMDAR-PrPC interaction. In mice primary neurons, we identified NMDA-PrPC complexes where PrPC was capable of blocking NMDAR-mediated effects. In addition, we observed how the presence of PrPC results in increased neurotoxicity and neuronal death. Similarly, in microglial primary cultures, we observed that PrPC caused a blockade of the NMDA receptor link to the MAPK signaling cascade. Interestingly, a significant increase in NMDA-PrPC macromolecular complexes was observed in cortical neurons isolated from the APP transgenic model of AD. Conclusions: PrPC can interact with the NMDAR, and the interaction results in the alteration of the receptor functionality. NMDAR-PrPC complexes are overexpressed in neurons of APP mouse brain. In addition, PrPC exacerbates axonal transport of Tau and pTau proteins.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Loss of presenilin function enhances tau phosphorylation and aggregation in mice

  • Soto Faguas, Carlos Manuel|||0000-0003-2954-4987
  • Sánchez Molina, Paula|||0000-0002-4124-5229
  • Saura Antolín, Carlos|||0000-0003-3692-5657
Mutations in the presenilin (PS/PSEN) genes encoding the catalytic components of γ-secretase accelerate amyloid-β (Aβ) and tau pathologies in familial Alzheimer's disease (AD). Although the mechanisms by which these mutations affect Aβ are well defined, the precise role PS/γ-secretase on tau pathology in neurodegeneration independently of Aβ is largely unclear. Here we report that neuronal PS deficiency in conditional knockout (cKO) mice results in age-dependent brain atrophy, inflammatory responses and accumulation of pathological tau in neurons and glial cells. Interestingly, genetic inactivation of presenilin 1 (PS1) or both PS genes in mutant human Tau transgenic mice exacerbates memory deficits by accelerating phosphorylation and aggregation of tau in excitatory neurons of vulnerable AD brain regions (e.g., hippocampus, cortex and amygdala). Remarkably, neurofilament (NF) light chain (NF-L) and phosphorylated NF are abnormally accumulated in the brain of Tau mice lacking PS. Synchrotron infrared microspectroscopy revealed aggregated and oligomeric β-sheet structures in amyloid plaque-free PS-deficient Tau mice. Hippocampal-dependent memory deficits are associated with synaptic tau accumulation and reduction of pre- and post-synaptic proteins in Tau mice. Thus, partial loss of PS/γ-secretase in neurons results in temporal- and spatial-dependent tau aggregation associated with memory deficits and neurodegeneration. Our findings show that tau phosphorylation and aggregation are key pathological processes that may underlie neurodegeneration caused by familial AD-linked PSEN mutations.